Cargando…

Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma

Dose-dependent toxicity and acquired resistance are two major challenges limiting the efficacious treatment of mammary carcinoma (MC) with doxorubicin. Herein, we investigated the function of Trefoil Factor 3 (TFF3) in the sensitivity and acquired resistance of estrogen receptor positive (ER+) MC ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poh, Han Ming, Chiou, Yi Shiou, Chong, Qing Yun, Chen, Ru-Mei, Rangappa, Kanchugarakoppal S., Ma, Lan, Zhu, Tao, Kumar, Alan Prem, Pandey, Vijay, Basappa, Lee, Soo-Chin, Lobie, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826976/ https://www.ncbi.nlm.nih.gov/pubmed/31658702 http://dx.doi.org/10.3390/cancers11101528

Ejemplares similares

Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK
por: Chen, Ru-Mei, et al.
Publicado: (2019)

Investigation of NPB Analogs That Target Phosphorylation of BAD-Ser99 in Human Mammary Carcinoma Cells
por: Girimanchanaika, Swamy Savvemala, et al.
Publicado: (2021)

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
por: Chong, Qing-Yun, et al.
Publicado: (2017)

Novel Biphenyl Amines Inhibit Oestrogen Receptor (ER)-α in ER-Positive Mammary Carcinoma Cells
por: Basappa, Basappa, et al.
Publicado: (2021)

Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2
por: Lau, Wai-Hoe, et al.
Publicado: (2015)

A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma
por: Zhang, Mengyi, et al.
Publicado: (2019)

Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase
por: Vishwanath, Divakar, et al.
Publicado: (2022)

Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
por: Cheng, Feifei, et al.
Publicado: (2022)

New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis
por: Barash, Uri, et al.
Publicado: (2021)

Anti-proliferative activity and characterization data on oxadiazole derivatives
por: Dukanya, et al.
Publicado: (2020)

Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer
por: Sebastian, Anusha, et al.
Publicado: (2016)

N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2018)

Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice
por: Buache, E, et al.
Publicado: (2011)

Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4
por: Bhuvanalakshmi, G., et al.
Publicado: (2017)

Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma
por: Lee, Jong Hyun, et al.
Publicado: (2019)

Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer
por: Ishibashi, Yuko, et al.
Publicado: (2017)

Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2018)

The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells
por: Lee, Jong Hyun, et al.
Publicado: (2019)

Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma
por: Zhang, Xi, et al.
Publicado: (2022)

Validation of the DNA Methylation Landscape of TFF1/TFF2 in Gastric Cancer
por: Qian, Ze, et al.
Publicado: (2022)

Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population
por: Jin, Eun-Heui, et al.
Publicado: (2015)

Electrochemical Synthesis of New Isoxazoles and Triazoles Tethered with Thiouracil Base as Inhibitors of Histone Deacetylases in Human Breast Cancer Cells
por: Vishwanath, Divakar, et al.
Publicado: (2023)

A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A(2)
por: Anilkumar, Nirvanappa C., et al.
Publicado: (2015)

Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity
por: Baburajeev, C. P., et al.
Publicado: (2017)

Novel Apigenin Based Small Molecule that Targets Snake Venom Metalloproteases
por: Srinivasa, Venkatachalaiah, et al.
Publicado: (2014)

Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer
por: Wu, Cheng-Shyong, et al.
Publicado: (2016)

Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2019)

Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma
por: Zhang, Xi, et al.
Publicado: (2022)

Differential Expression of TFF1 and TFF3 in Patients Suffering from Chronic Rhinosinusitis with Nasal Polyposis
por: Mihalj, Martina, et al.
Publicado: (2019)

Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma
por: Pandey, Vijay, et al.
Publicado: (2014)

Reduced Expression of TFF1 and Increased Expression of TFF3 in Gastric Cancer: Correlation with Clinicopathological Parameters and Prognosis
por: Im, Soyoung, et al.
Publicado: (2012)

Prognostic significance of the expression of GFRα1, GFRα3 and Syndecan-3, proteins binding ARTEMIN, in mammary carcinoma
por: Wu, Zheng-Sheng, et al.
Publicado: (2013)

Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells
por: Basappa, Basappa, et al.
Publicado: (2023)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Synthesis and Characterization of Novel 2-Amino-Chromene-Nitriles that Target Bcl-2 in Acute Myeloid Leukemia Cell Lines
por: Keerthy, Hosadurga K., et al.
Publicado: (2014)

Development of 1-(4-(Substituted)piperazin-1-yl)-2-((2-((4-methoxybenzyl)thio)pyrimidin-4-yl)oxy)ethanones That Target Poly (ADP-Ribose) Polymerase in Human Breast Cancer Cells
por: Deveshegowda, Suresha N., et al.
Publicado: (2022)

Novel Benzoxazine-Based Aglycones Block Glucose Uptake In Vivo by Inhibiting Glycosidases
por: Bharathkumar, Hanumantharayappa, et al.
Publicado: (2014)

A Nano-MgO and Ionic Liquid-Catalyzed ‘Green’ Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51)
por: Anusha, Sebastian, et al.
Publicado: (2015)

Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules as Inducers of JNK Phosphorylation through ROS Generation in Breast Cancer Cells
por: Kim, Na Young, et al.
Publicado: (2023)

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma
por: Banerjee, Arindam, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qno9pt872s14c6dr52l7aco4ab